Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

They did have two drugs fail in trials. As yet, that has not happened to us and hopefully won't. We already know the LM platform is capable of mounting an immune response. We've had some complete responses. I am betting (aren't we all) that AXAL and the other constructs may work even better as NEO, HOT, combined with PD-1 inhibitors and whatever else is coming down the pike. A lot has been posted here of antiquated technology, competition and other obstacles. This holds true for any oncology company now developing a treatment. There will always be a newer, better treatment on the horizon. If the LM platform can evolve to be combined with any, most or all of these, and increase chances of a better outcome we'll be around for a long while.